Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C
<p><strong>Background:</strong> This study aimed to determine the role of tumor markers AFP, CA15-3, CA125, CA19-9 and CEA in patients with hepatitis B and C.</p><p><strong>Methods</strong>: This descriptive cross-sectional study was performed from Oct 2012...
Main Authors: | Mehdi ASSMAR, Sara YEGANEH, Fariborz MANSOURGHANAEI, Nour AMIRMOZAFARI |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-12-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | http://ijph.tums.ac.ir/index.php/ijph/article/view/8640 |
Similar Items
-
Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
by: Fan Feng, et al.
Published: (2017-11-01) -
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
by: Ramona C Dolscheid-Pommerich, et al.
Published: (2017-10-01) -
Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma
by: Muhammad Ibrahim Alhadi EDOO, et al.
Published: (2019-02-01) -
Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19‐9, CA15‐3, CA125, PSA, HE4, Cyfra 21‐1, and ProGRP) in primary care centers in Korea: A cross‐sectional retrospective study
by: Eun‐Hee Nah, et al.
Published: (2023-02-01) -
Evaluating Lung Cancer with Tumor Markers: CEA, CA 19-9 and CA 125
by: Aydın Balcı, et al.
Published: (2021-05-01)